Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...

After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...

Proteus takes a meticulous, “anti-Theranos” approach to growth and navigating the hurdles of creating a new category of medical device. Following Theranos’ fraudulent unraveling, two separate Food and ...

Proteus (News - Alert) Biomedical recently announced European Union approval of its ingestible sensor and personal physiologic monitor system. The sensors are designed to be safe to swallow in order ...

REDWOOD CITY, Calif. – July 30, 2012 – Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

With Proteus Digital Health's tracker riding in a tablet treating mental health disorders, patients (and their caregivers and doctors) will be able to tell that the medicine has been ingested. A ...

Agreement will exploit Proteus’ technologies designed to provide feedback on factors such as patient physiology and compliance. Proteus Biomedical will receive $24 million worth of cash and equity ...

Proteus Digital Health has announced it has received FDA clearance for an ingestible sensor, according to a news release. The ingestible sensor, formally referred to as the Ingestion Event Marker, can ...